KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term InvestmentsNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsSecuritiesSecurities - Held-to-maturitySecurities - TradableShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Peoples Bancorp (PEBO) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Peoples Bancorp (PEBO) over the last 10 years, with Q3 2025 value amounting to $190.2 million.

  • Peoples Bancorp's Cash & Equivalents fell 3295.3% to $190.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $190.2 million, marking a year-over-year decrease of 3295.3%. This contributed to the annual value of $217.7 million for FY2024, which is 4899.16% down from last year.
  • As of Q3 2025, Peoples Bancorp's Cash & Equivalents stood at $190.2 million, which was down 3295.3% from $186.1 million recorded in Q2 2025.
  • Peoples Bancorp's Cash & Equivalents' 5-year high stood at $499.7 million during Q3 2021, with a 5-year trough of $15.0 million in Q4 2022.
  • For the 5-year period, Peoples Bancorp's Cash & Equivalents averaged around $246.7 million, with its median value being $217.7 million (2024).
  • Per our database at Business Quant, Peoples Bancorp's Cash & Equivalents tumbled by 7094.47% in 2022 and then skyrocketed by 274272.87% in 2023.
  • Over the past 5 years, Peoples Bancorp's Cash & Equivalents (Quarter) stood at $15.3 million in 2021, then dropped by 1.58% to $15.0 million in 2022, then surged by 2742.73% to $426.7 million in 2023, then crashed by 48.99% to $217.7 million in 2024, then fell by 12.61% to $190.2 million in 2025.
  • Its Cash & Equivalents was $190.2 million in Q3 2025, compared to $186.1 million in Q2 2025 and $187.0 million in Q1 2025.